Cell Therapeutics Limited (UK) Company Profile

07:07 EDT 23rd March 2018 | BioPortfolio

At CTI, we're taking a different approach to the treatment of cancer—one focused on developing, acquiring, and commercializing therapies to combat the disease without compromising patient quality of life. Our goal is safer, more effective cancer therapies that can make a meaningful difference to millions.

Frequent conversations with medical professionals and their patients, financial analysts, media representatives and our own employees, have helped us design a Web site that we hope provides the information you seek. Our site includes general corporate information, descriptions of research advances, marketed drugs and product candidates, patient information, and career opportunities. Please explore our site to discover the innovation of our technologies and the commitment of our employees to making cancer a more treatable disease.


1 Ropemaker Street
United Kingdom


Phone: +44 (0) 208 895 4004
Fax: +44 (0) 208 894 4204

News Articles [2206 Associated News Articles listed on BioPortfolio]

VIDEO: BrainStorm Cell Therapeutics Seeks JVs And Investors To Commercialize Stem Cell Pipeline

Chaim Lebovits, president and CEO of BrainStorm Cell Therapeutics, discusses the company's stem cell trials in ALS and other ventures...   

Appointment of Director

Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...

Rubius raises $100m funding to further support red-cell therapeutics development

US-based biotechnology company Rubius Therapeutics has raised $100m crossover financing to further support manufacturing and clinical development of red-cell therapeutics.

TCR2 Therapeutics Snags $125 Million To Expand T-Cell Program

TCR2 Therapeutics has raised $125 million in Series B financing to advance two T-Cell receptor (TCR) programs through clinical proof-of-concept.

Belgian Firm Raises €19M to Fix Spinal Fusion with Cell Therapy

Bone Therapeutics has raised €19.5M through a private placement that will fund the completion of clinical trials testing its cell therapy for spinal fusion and other bone diseases.  Based in Grosel...

Rubius closes Series C round of more than $100mm

Rubius Therapeutics Inc. (cell therapies) raised $101.2mm in an oversubscribed Series C financing. According to the Form D, 27 investors participated. The company is developing Red-Cell Therapeutics (...

Kite, Sangamo Therapeutics Collab to Develop Next-generation Engineered Cell Therapies for the Treatment of Cancer

NewsKite and Sangamo Therapeutics announced the companies have entered into a worldwide collaboration using Sangamo’s zinc finger nuclease (ZFN) technology platform for the development of next-gener...

Abeona Therapeutics Inc: Abeona Therapeutics Announces Upcoming Presentations at the 14th Annual WORLDSymposium

NEW YORK and CLEVELAND, 2018-02-02 14:45 CET (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene...

PubMed Articles [3314 Associated PubMed Articles listed on BioPortfolio]

Developing T-cell therapies for lymphoma without receptor engineering.

T-cell therapy has emerged from the bench for the treatment of patients with lymphoma. Responses to T-cell therapeutics are regulated by multiple factors, including the patient's immune system status ...

Receptor-Mediated Uptake of Phosphorothioate Antisense Oligonucleotides in Different Cell Types of the Liver.

Oligonucleotide therapeutics have emerged as a third distinct platform for drug discovery within the pharmaceutical industry. Five oligonucleotide-based drugs have been approved by the US FDA and over...

Cancer Cell Controller.

Cancer is the disease which exists when the cell is uncontrolled. This paper presents a controller for the same. The cancer cell is reviewed via algebraic structures.

Non-protein biologic therapeutics.

While the therapeutic biologics are dominated by therapeutic proteins, particularly monoclonal antibodies, a wide range of non-protein therapeutic biologics are rapidly gaining ground both in clinical...

Regenerative Rehabilitation: Applied Biophysics Meets Stem Cell Therapeutics.

The emerging field of regenerative rehabilitation integrates biological and bioengineering advances in regenerative medicine with rehabilitative sciences. Here we highlight recent stem cell-based exam...

Clinical Trials [5831 Associated Clinical Trials listed on BioPortfolio]

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease

This study evaluates the safety and clinical benefits of a therapeutics approach of conditioning regimen Cyclophosphamide (Cy) + Thymoglobulin r (ATG) + Granulocyte Colony-Stimulating Fact...

Companies [2149 Associated Companies listed on BioPortfolio]

Magenta Therapeutics

Magenta Therapeutics is a biotechnology company harnessing the power of stem cell science to revolutionize stem cell transplantation for patients with immune- and blood-based dise...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

Opsis Therapeutics

Opsis Therapeutics is a company focused on discovering and developing new medicines to restore vision to patients suffering from retinal diseases. By combining recent innovations ...

Stem Cell Therapeutics Corp.

Stem Cell Therapeutics is a publicly listed Canadian biotechnology company headquartered in Calgary, Alberta. The company is focused on the development and commercialization of Therapeutics that contr...

Fate Therapeutics Inc.

Founded in 2007 on the leading stem cell and developmental biology research, Fate Therapeutics is using the fundamental biological mechanisms that guide cell fate to develop stem cell therapeutics. Th...

More Information about "Cell Therapeutics Limited (UK)" on BioPortfolio

We have published hundreds of Cell Therapeutics Limited (UK) news stories on BioPortfolio along with dozens of Cell Therapeutics Limited (UK) Clinical Trials and PubMed Articles about Cell Therapeutics Limited (UK) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell Therapeutics Limited (UK) Companies in our database. You can also find out about relevant Cell Therapeutics Limited (UK) Drugs and Medications on this site too.

Quick Search


Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Corporate Database Quicklinks

Searches Linking to this Company Record